Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry

Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic

(2016) Megan E. Kleinow et al.   JOURNAL OF MANAGED CARE PHARMACY

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

(2014) J. Beyer-Westendorf et al.   BLOOD

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

(2014) François Laliberté et al.   CURRENT MEDICAL RESEARCH AND OPINION

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

(2014) J. Beyer-Westendorf et al.   EUROPEAN HEART JOURNAL

Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation

(2013) Winnie W. Nelson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

(2012) Tara Gomes et al.   ARCHIVES OF INTERNAL MEDICINE

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation

(2010) Margaret C. Fang et al.  

Could Geriatric Characteristics Explain the Under-Prescription of Anticoagulation Therapy for Older Patients Admitted with Atrial Fibrillation?

(2010) Sandra De Breucker et al.   DRUGS & AGING

Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications

(2009) N. A. Limdi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

(2008) R. Nieuwlaat et al.   EUROPEAN HEART JOURNAL

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

(2008) A. M. GALLAGHER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS